miR Scientific Is Transforming Cancer Management Into What It Should Be

miR Scientific is a precision bioscience company developing non-invasive liquid biopsy urine tests that accurately detect and precisely classify prostate and bladder cancers at the molecular level with industry-leading Sensitivity and Specificity.

Our molecular diagnostic capabilities approach cancer detection, classification, and monitoring through a new lens with advanced sncRNA interrogation techniques, a proprietary scoring algorithm, and innovative clinical decision support tools.

The miR Disease Management Platform delivers breakthrough ease and accuracy of cancer diagnosis and characterization with actionable clinical pathways across the continuum of care.

The miR Leadership Team

Sam Salman

Co-Founder, Chairman & CEO

Martin Tenniswood, Ph.D

Co-Founder & Chief Scientific Officer

Rob Tenniswood

Co-Founder, Chief Operating Officer & President - Canada

Laurence Klotz, MD, FRCSC, CM

Chief Medical Officer

Wei-Lin “Winnie” Wang, Ph.D

Director of Clinical Research

Gregory DiRienzo, Ph.D

Director of Biostatistics

Jill Anderson, JD

Chief Legal Officer

Tal Kimmel

Chief Strategy Officer

Deborah Fine

Chief Marketing Officer, Vice Chair, Executive Committee

Austin Srejma

Vice President, Operations

Bob Flippin

Chief Administrative Officer

Arminda Figueroa

Chief of Staff – Country Manager

Eli Mor

General Manager, miR Scientific Israel

John Dvor

Executive Vice President, Corporate Development

Keren Nir

Vice President, Operations Israel

Norma Prus

Director of People and Culture

Rob Francess, CPA

Global Controller

Stuart Kozlick

Senior Vice President - Canada


Sebastiano Cossia Castiglioni

Deepak A. Kapoor, MD

Alejandro Weinstein

Henry Weinstein

Scientific Advisory Board

Andrew Armstrong, MD

Sam Chang, MD MBA

Yuval Eshdat, Ph.D

Phillip C. Ginsberg, DO, JD

David Josephson, MD

James M. Libby, MD

James M. McKiernan, MD

Geoffrey Sonn, MD

Work At miR

Join a passionate, talented group of scientists, physicians, and business leaders to drive historic change in healthcare

miR Careers

miR Scientific is a majority-owned operating subsidiary of Impact NRS, headquartered in New York with operating subsidiaries in Canada and Israel.

Impact NRS is a leading innovation company developing transformative solutions to address persistent global challenges in human health, sustainable food production and agriculture. Their model incorporates breakthrough advances in science, statistics and computation to develop products and services for early and scalable adoption. Impact NRS collaborates with stakeholders worldwide to enable rapid commercialization of their ESG socially responsible initiatives.